Trials / Recruiting
RecruitingNCT06579573
ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.
ONO-2017 Phase III Study A Multicenter, Open-label Study in Japanese Patients With Primary Generalized Tonic Clonic Seizures.
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the efficacy and safety of ONO-2017 in combination with antiepileptics in Japanese epileptic patients with generalized tonic-clonic seizures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cenobamate | Cenobamate will be orally administered once daily. |
Timeline
- Start date
- 2022-07-12
- Primary completion
- 2027-01-31
- Completion
- 2027-01-31
- First posted
- 2024-08-30
- Last updated
- 2025-06-17
Locations
25 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT06579573. Inclusion in this directory is not an endorsement.